Clinical Trials Logo

Filter by:
NCT ID: NCT01434290 Completed - Prostate Cancer Clinical Trials

Radiation Therapy in Treating Patients With Prostate Cancer

Start date: September 2011
Phase: Phase 2
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Given radiation therapy in different ways may kill more tumor cells. PURPOSE: This randomized phase II trial studies radiation therapy to see how well it works in treating patients with prostate cancer.

NCT ID: NCT01434186 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Start date: May 2012
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118) in combination with Metformin in pediatric patients with type 2 diabetes

NCT ID: NCT01433939 Completed - Clinical trials for Colonoscopy Technique

Position Changes During Colonoscope Insertion Increases Patient Comfort

Start date: September 2011
Phase:
Study type: Observational

The investigators wish to study the effects of position changes during colonoscope insertion on patient comfort. The investigators hypothesize that early position changes would reduce colonoscope loop formation and patient discomfort.

NCT ID: NCT01433588 Completed - Acute Pain Clinical Trials

The Calmer Project

Start date: October 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to see if the Calmer is more effective at managing acute pain in preterm infants in the neonatal intensive care than the current standard of care in the unit. Hypothesis: While receiving treatment with Calmer, infants will show lower behavioral pain scores and lower heart rates, and more stable autonomic regulation as measured by heart rate variability indices, than infants given a soother plus facilitated tucking (standard of care) during routine blood collection.

NCT ID: NCT01433549 Completed - Myopia Clinical Trials

Lens Wear Schedules and End-of-Day Comfort

INVERMERE
Start date: August 2011
Phase: N/A
Study type: Interventional

The purpose of this study was to assess the impact of lens-free (recovery) intervals of varying lengths on end-of-day comfort and tear film changes with daily contact lens wear.

NCT ID: NCT01432444 Completed - Schizophrenia Clinical Trials

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

ARRIVE US
Start date: September 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare retrospective hospitalization rates of schizophrenic patients treated with oral antipsychotics to prospective hospitalization rates of these patients treated with IM depot aripiprazole.

NCT ID: NCT01432418 Completed - Movement Disorders Clinical Trials

Effectiveness of a Wheelchair Skills Training Program for Power Mobility Users: A Randomized Controlled Trial

Start date: June 2012
Phase: N/A
Study type: Interventional

This is a 3-year multi-centre, single-blinded, randomized controlled trial (RCT) to test the hypothesis that wheelchair skills training (using a systematic training program called the Wheelchair Skills Training Program) improves wheelchair skills and safety of 144 powered wheelchair users. A second objective is to assess the effects of age, sex, training centre, and participant experience on outcomes, assessing the retention of benefits and assessing the impact of training on other important outcomes.

NCT ID: NCT01432236 Completed - Fibromyalgia Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Start date: October 2011
Phase: Phase 3
Study type: Interventional

The intent of this study is to identify and treat fibromyalgia subjects with comorbid depression who are receiving an SSRI (selective serotonin reuptake inhibitor) or SNRI (selective norepinephrine reuptake inhibitor) primarily for their depression and to determine whether pregabalin demonstrates improvement relative to placebo in improving pain associated with fibromyalgia.

NCT ID: NCT01432184 Completed - Cerebral Hypoxia Clinical Trials

Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery

Tête-à-coeur
Start date: July 2010
Phase: N/A
Study type: Interventional

Using the brain and the heart as index organs, perioperative interventions to optimize cerebral oxygen saturation and cardiac contractility in high-risk patients undergoing cardiac surgery should have a beneficial systemic effect for enhancing global tissue perfusion and improve outcomes.

NCT ID: NCT01431716 Completed - Clinical trials for Pulmonary Arterial Hypertension

Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension

EPITOME-2
Start date: March 2011
Phase: Phase 3
Study type: Interventional

This study is investigating the effect of switching from Flolan® to Epoprostenol for Injection (EFI/ACT-385781A) in pulmonary arterial hypertension patients currently treated with Flolan®. For this purpose patients being treated for at least 12 months with Flolan® will be switched from Flolan® to EFI/ACT-385781A and followed-up for 90 days. During these 90 days safety and tolerability of EFI/ACT-385781A will closely be monitored in all treated patients. This 90 follow-up will provide clinical evidence on the safety, tolerability, efficacy and treatment satisfaction of switching from Flolan® to EFI/ACT-385781A in patients with pulmonary arterial hypertension.